COVID-19 pandemic is a rapidly evolving public health emergency. Conventional pharmacotherapy used in its management is supportive. Although mild presentation of the disease counts for the largest group of infected people with SARS-CoV-2, no targeted therapy is offered for clinical improvement. A confirmed case of COVID-19 with mild illness was treated with Ayurvedic medicines via remote consultation. Ayurvedic treatment, in this case, was directed towards alleviating symptoms and minimising the chances of progression of disease. Disequilibrium of dosha-dhatu-malas in a presented case was evaluated. Roles of Vata dosha, kapha dosha, Rasa dhatu and Pranavaha strotasa were identified. A decoction of Draksha (Vitis vinifera), Haridra (Curcuma longa), Shunthi (Zinziber officinale) and Yashtimadhu (Glycyrrhiza glabra) was
administered thrice a day for 7 days. Gargles with Haridra (turmeric) medicated warm water were advised twice a day. Pathya-apathya were suggested as a complete plan of therapeutic regimen. The patient experienced satisfactory clinical improvement on 6th day of the treatment. No adverse effects associated with the treatment were observed. Thus, there is a possibility that, Ayurveda medicines that are well known for their safety since thousands of years, might emerge as safe and effective solution for managing mild cases of COVID-19 even through telemedicine and reduce strain on over-stressed public health infrastructure.
Key words: COVID-19; Ayurveda; mild cases; SARS-CoV-2
|
